|
Session 7
Oral Abstracts
Epidemiology of SIV/HIV Infection and AIDS-related Malignancies
Monday, 10 am-12 noon
Room: Room 302-304 |
| 10:00 am 10 |
Geographic Distribution of SIVgor in Wild-living Gorillas from Cameroon
Cecile Neel*1,2, F Van Heuverswyn1, E Mpoudi Ngole2, Y Li3, B Keele3, F Liegeois1, C Butel1, E Delaporte1, B Hahn3, and M Peeters1
1UMR145, Inst for Res and Devt, Univ of Montpellier 1, France; 2PRESICA, Yaounde, Cameroon; and 3Univ of Alabama at Birmingham, US |
| 10:15 am 11 |
Diagnosis and Monitoring of HIV-1 Group O Infections in Cameroon
Aurelia Vessiere*1, D Rousset1, M Leoz2, A Depatureaux2, F Simon3, and J C Plantier2
1Ctr Pasteur of Cameroon, Yaounde; 2Hosp Charles Nicolle, Rouen, France; and 3Hosp St Louis, Paris, France |
| 10:30 am 12 |
New and Old Complex Recombinant HIV-1 Strains Entering in France among Patients with Primary Infection in 2004 to 2006: Tthe French ANRS CO06 Primo Cohort Study
P Frange1, J Galimand1, M Peeters2, C Goujard3, C Deveau4, V Avettand - Fenoel1, F Souala5, L Meyer4, C Rouzioux1, and Marie-Laure Chaix*1
1Ctr Hosp Univ Necker, Paris, France; 2Inst for Res and Devt, Montpellier, France; 3Ctr Hosp Univ Bicetre, Le Kremlin-Bicetre, France; 4INSERM, Le Kremlin Bicetre, France; and 5Ctr Hosp Univ Pontchaillou, Rennes, France |
| 10:45 am 13 |
Recent Phylodynamics of the HIV Epidemic among MSM in the UK
Gareth Hughes*1, A Leigh Brown1, A Rambaut1, S Lycett1, F Lewis2, E Fearnhill3, and UK Collaborative Group on HIV Drug Resistance
1Univ of Edinburgh, Scotland; 2Scottish Agricultural Coll, Inverness, UK; and 3Med Res Council Clinical Trials Unit, London, UK |
| 11:00 am 14 |
Changes Over Time in the Risk of Death following HIV Seroconversion Compared with Mortality in the General Population
Kholoud Porter*1, O Hamouda2, M Sannes3, F Boufassa4, A Johnson5, S Walker1, and CASCADE Collaboration
1Med Res Council Clinical Trials Unit, London, UK; 2Robert Koch Inst, Germany; 3Ulleval Univ Hosp, Oslo, Norway; 4INSERM, Paris, France; and 5Univ Coll London, UK |
| 11:15 am 15 |
Immunodeficiency and Risk of AIDS-defining and Non-AIDS-defining Cancers: ANRS CO3 Aquitaine Cohort, 1998 to 2006
M Bruyand1,2, R Thiebaut1,2,3,4, S Lawson-Ayayi1,2, P Joly3,4, A Sasco5, J L Pellegrin2,4,6, D Neau2,4,6, P Morlat1,2,4,6, G Chene1,2,4, Fabrice Bonnet*1,2,4,6, and Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
1INSERM U593 and CIC-EC7, Bordeaux, France; 2Ctr Hosp Univ Bordeaux, France; 3INSERM U875, Bordeaux, France; 4Univ Victor Segalen, Bordeaux, France; 5INSERM U897, Bordeaux, France; and 6Ctr Hosp Univ Bordeaux, France |
| 11:30 am 16 |
Insufficient Virus Suppression during HAART Is a Strong Predictor for the Development of AIDS-related Lymphoma: German CLINSURV Cohort
Alexander Zoufaly*1, H J Stellbrink2, M an der Heiden3, C Kollan3, J van Lunzen1, O Hamouda3, and CLINSURV Study group
1Univ Med Ctr Hamburg-Eppendorf, Germany; 2IPM Study Ctr, Hamburg, Germany; and 3Robert Koch Inst, Berlin, Germany |
|
